Enzyme Inhibitors

Publication Title: 
Respiratory Medicine

BACKGROUND: Many options are available for preventing people from getting infected by influenza virus, with vaccination being the most widely used. METHODS: We assessed the evidence available in Cochrane systematic reviews. We found nine reviews, five of them addressing influenza vaccination, and four addressing medication. RESULTS: Vaccination is effective in healthy adults and children, but the effect is modest in adults, and for young children few data are available.

Author(s): 
van der Wouden, J. C.
Bueving, H. J.
Poole, P.
Publication Title: 
The Journal of Dermatological Treatment

BACKGROUND: Systemic therapies are routinely used for the management of cutaneous warts. However, there is a lack of evidence-based data on their effectiveness. OBJECTIVE: To assess the evidence for the efficacy of systemic treatments for cutaneous warts. METHODS: We designed a systematic review of the randomized controlled clinical trials (1962 to April 2010) investigating systemic therapies for the treatment of cutaneous warts. We obtained data from MEDLINE, PubMed, Current Contents, reference lists, and specialist textbooks, with no restriction on language.

Author(s): 
Simonart, Thierry
de Maertelaer, Viviane
Publication Title: 
Chemical & Pharmaceutical Bulletin

Extracts of 41 medicinal plants used in Egyptian folk medicine were screened for their inhibitory effects on human immunodeficiency virus-1 reverse transcriptase. The extracts of fruits of Phyllanthus emblica, Quercus pedunculata, Rumex cyprius, Terminalia bellerica, Terminalia chebula and Terminalia horrida showed significant inhibitory activity with IC50 < or = 50 micrograms/ml. Through a bioassay guided-fractionation of the methanol extract of the fruit of P.

Author(s): 
el-Mekkawy, S.
Meselhy, M. R.
Kusumoto, I. T.
Kadota, S.
Hattori, M.
Namba, T.
Publication Title: 
Biological & Pharmaceutical Bulletin

Gallic acid (GA) and chebulagic acid (CA) were isolated from the extract of a herbal medicine, kashi (myrobalans: the fruit of Terminalia chebula) as active principles that blocked the cytotoxic T lymphocyte (CTL)-mediated cytotoxicity. GA and CA inhibited the killing activity of CD8+ CTL clone at IC50 values of 30 microM and 50 microM, respectively. Granule exocytosis in response to anti-CD3 stimulation was also blocked by GA and CA at the equivalent concentrations.

Author(s): 
Hamada, S.
Kataoka, T.
Woo, J. T.
Yamada, A.
Yoshida, T.
Nishimura, T.
Otake, N.
Nagai, K.
Publication Title: 
Canadian Journal of Physiology and Pharmacology

Padma 28 is a mixture of herbs used in traditional Tibetan medicine with anti-inflammatory activities. We investigated the effects of Padma 28 on nitric oxide (NO) production by the inducible nitric oxide synthase (iNOS) in lipopolysaccharide stimulated mouse macrophages (RAW 264.7). Padma 28 (0-900 microg/mL) induced a concentration dependent inhibition of inducible nitric oxide synthesis. iNOS protein expression showed a concentration dependent reduction as revealed by immunoblotting when cells were incubated with increasing amounts of Padma 28.

Author(s): 
Moeslinger, T.
Friedl, R.
Volf, I.
Brunner, M.
Koller, E.
Spieckermann, P. G.
Publication Title: 
Journal of Biosciences

Myrrh (guggulu) oleoresin from the Commiphora mukul tree is an important component of antiarthritic drugs in Ayurvedic medicine. Clinical data suggest that elevated levels of hyaluronidase and collagenase type 2 enzymes contribute significantly to cartilage degradation. Triphala guggulu (TG) is a guggulu-based formulation used for the treatment of arthritis. We assessed the chondroprotective potential of TG by examining its effects on the activities of pure hyaluronidase and collagenase type 2 enzymes.

Author(s): 
Sumantran, Venil N.
Kulkarni, Asavari A.
Harsulkar, Abhay
Wele, Asmita
Koppikar, Soumya J.
Chandwaskar, Rucha
Gaire, Vishakha
Dalvi, Madhuri
Wagh, Ulhas V.
Publication Title: 
Bioscience, Biotechnology, and Biochemistry

Chebulagic acid, isolated form Terminalia chebula Retz, proved to be a reversible and non-competitive inhibitor of maltase with a K(i) value of 6.6 muM. The inhibitory influence of chebulagic acid on the maltase-glucoamylase complex was more potent than on the sucrase-isomaltase complex. The magnitude of alpha-glucosidase inhibition by chebulagic acid was greatly affected by its origin. These results show a use for chebulagic acid in managing type-2 diabetes.

Author(s): 
Gao, Hong
Huang, Yi-Na
Gao, Bo
Kawabata, Jun
Publication Title: 
Reproductive Toxicology (Elmsford, N.Y.)

Our interest in development of hyaluronidase inhibitors as male antifertility agents led to identification of Terminalia chebula (T. chebula) plant with hyaluronidase (HAase) inhibitory activity of human spermatozoa ( approximately 93% inhibition) and rat caudal epididymal spermatozoa ( approximately 86% inhibition) in vitro at 30 mg/ml.

Author(s): 
Srivastav, Archana
Chandra, Abhishek
Singh, Madhulika
Jamal, Farrukh
Rastogi, Preeti
Rajendran, Siron Mani
Bansode, Falgun Wanganuji
Lakshmi, Vijai
Publication Title: 
Chemosphere

Effect of active molluscicidal components of Sapindus mukorossi and Terminalia chebula on the acetylcholinesterase (AChE), acid and alkaline phosphatase (ACP/ALP) activity in the nervous tissue of freshwater snail Lymnaea acuminata were studied. In vivo and in vitro exposure of saponin (active component of S. mukorossi pericarp) and tannic acid (active component of T. chebula) significantly inhibited the AChE, ACP and ALP activity in the nervous tissue of L. acuminata.

Author(s): 
Upadhyay, Aparna
Singh, Dinesh K.
Publication Title: 
Journal of Enzyme Inhibition and Medicinal Chemistry

Terminalia chebula fruit extracts were prepared sequentially with hexane, ethyl acetate, methanol and methanol-water (70:30) and tested for their ?-glucosidase inhibitory and antioxidant potential. The study resulted in the formulation of an extract with high ?-glucosidase inhibitory potential (IC(50) 0.19 ± 0.03 µg mL(-1)) enriched with hydrolysable tannins.

Author(s): 
Sasidharan, Indu
Sundaresan, A.
Nisha, V. M.
Kirishna, Mahesh S.
Raghu, K. G.
Jayamurthy, P.

Pages

Subscribe to RSS - Enzyme Inhibitors